Claudio Corallo
Overview
Explore the profile of Claudio Corallo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
High-throughput 3D microvessel-on-a-chip model to study defective angiogenesis in systemic sclerosis
Kramer B, Corallo C, van den Heuvel A, Crawford J, Olivier T, Elstak E, et al.
Sci Rep
. 2022 Oct;
12(1):16930.
PMID: 36209279
In early systemic sclerosis (Scleroderma, SSc), the vasculature is impaired. Although the exact etiology of endothelial cell damage in SSc remains unclear, it is hypothesized that endothelial to mesenchymal transition...
2.
Giordano N, Corallo C, Chirico C, Brazzi A, Marinetti A, Fioravanti A, et al.
J Scleroderma Relat Disord
. 2022 Apr;
4(1):35-42.
PMID: 35382146
Scleroderma (systemic sclerosis) is an autoimmune connective tissue disease which presents endothelial dysfunction and fibroblast dysregulation, resulting in vascular and fibrotic disorders. Pulmonary hypertension is frequent in patients with systemic...
3.
Cutolo M, Soldano S, Montagna P, Martinelli G, Tardito S, Corallo C, et al.
Rheumatology (Oxford)
. 2020 Jul;
59(12):3927-3938.
PMID: 32725130
Objectives: Fibroblast-to-myofibroblast transition and extracellular matrix overproduction represent progressive events in chronic inflammatory and fibrotic diseases, in which TGFβ1 is one of the key mediators. Phosphodiesterase 4 (PDE4) acts as...
4.
Cheleschi S, Tenti S, Mondanelli N, Corallo C, Barbarino M, Giannotti S, et al.
Cells
. 2019 Aug;
8(8).
PMID: 31405216
Current evidence suggests a complex interaction between adipokines and microRNA (miRNA) in osteoarthritis (OA) pathogenesis. The present study explored the role of miR-34a and miR-181a in regulating apoptosis and oxidative...
5.
Corallo C, Fioravanti A, Tenti S, Pecetti G, Nuti R, Giordano N
Rheumatol Int
. 2019 Aug;
39(10):1767-1775.
PMID: 31372720
We evaluated the presence of sarcopenia in a population of systemic sclerosis (SSc) patients, with respect to nutritional, clinical, and laboratory features. A total of 62 patients who met the...
6.
Corallo C, Pinto A, Renieri A, Cheleschi S, Fioravanti A, Cutolo M, et al.
Clin Exp Rheumatol
. 2019 Aug;
37 Suppl 119(4):69-75.
PMID: 31365333
Objectives: Relaxin is a potent anti-fibrotic hormone that has been tested to ameliorate fibrosis in systemic sclerosis (SSc), but with controversial results. The aim of the study is to sequence...
7.
Corallo C, Cheleschi S, Cutolo M, Soldano S, Fioravanti A, Volpi N, et al.
Arthritis Res Ther
. 2019 Jun;
21(1):152.
PMID: 31234888
Background: The importance of systemic sclerosis (SSc) autoantibodies for diagnosis has become recognized by their incorporation into the 2013 ACR/EULAR classification criteria. Clear prognostic and phenotypic associations with cutaneous subtype...
8.
Cutolo M, Ruaro B, Montagna P, Brizzolara R, Stratta E, Trombetta A, et al.
Arthritis Res Ther
. 2018 May;
20(1):77.
PMID: 29720235
Background: Myofibroblasts contribute to fibrosis through the overproduction of extracellular matrix (ECM) proteins, primarily type I collagen (COL-1) and fibronectin (FN), a process which is mediated in systemic sclerosis (SSc)...
9.
Brogi S, Maramai S, Brindisi M, Chemi G, Porcari V, Corallo C, et al.
ChemMedChem
. 2017 Nov;
12(24):2074-2085.
PMID: 29131552
A computational analysis of the X-ray structure of the low-density lipoprotein receptor-related protein 6 (LRP6) with the Dickkopf-1 (DKK1) C-terminal fragment has allowed us to rationally design a small set...
10.
Soldano S, Paolino S, Pizzorni C, Trombetta A, Montagna P, Brizzolara R, et al.
Clin Exp Rheumatol
. 2017 Jan;
35(3):484-493.
PMID: 28134077
Objectives: To evaluate the ability of dual endothelin (ET) receptor antagonists (ETA/ETB -ETA/BRAs) to contrast the ET-1-induced effects on cultured human microvascular endothelial cells (HMVECs). Methods: Some cultured HMVECs were...